Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCR2-64I is a risk factor for development of bladder cancer.

Genetics and molecular research : GMR - 13 Apr 2010

Narter K F, Agachan B, Sozen S, Cincin Z B, Isbir T

Abstract excerpt

Chemokines are potent proinflammatory cytokines that are implicated in numerous inflammatory diseases. Proinflammatory gene polymorphisms lead to variations in the production and concentration of inflammatory proteins. We investigated a possible association between polymorphisms in chemokine and chemokine receptor genes (MCP-1 A-2518G and CCR2-V64I) and bladder cancer risk. Genotypes were determined by PCR-RFLP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Haplotypes
Share to Logistic Models
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokine CCL2

Share to Multivariate Analysis

Share to Precancerous Conditions

Share to Receptors, CCR2

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 20449800
DOI: 10.4238/vol9-2gmr829

Genes

CCR2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCR2-64I is a risk factor for development of bladder cancer.PMID 20449800Read ↗

Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.Semantic proximity Read ↗

Toll-like receptor 4 gene polymorphisms and susceptibility to bladder cancer.Semantic proximity Read ↗

The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.Semantic proximity Read ↗

Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.Semantic proximity Read ↗

MCP‐1 and CCR2 gene variants in oral squamous cell carcinomaSemantic proximity Read ↗

Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.Semantic proximity Read ↗

Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer.Semantic proximity Read ↗

Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.Semantic proximity Read ↗

Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.Semantic proximity Read ↗

Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.Semantic proximity Read ↗

CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.